Common Eye Ointments Linked to Potential Failure of Glaucoma Implants
Published: 2026/01/16 11:48:12
For the millions worldwide living with glaucoma, implants like the PRESERFLO MicroShunt offer a crucial pathway to preserving vision. Though, groundbreaking new research from Nagoya University in Japan reveals a surprising threat to the long-term success of these implants: common, over-the-counter petrolatum-based eye ointments. This study, the first to demonstrate a link through both clinical and experimental evidence, suggests these seemingly harmless ointments can cause the MicroShunt to swell and, in severe cases, even rupture, potentially leading to implant failure and vision loss.
Understanding Glaucoma and the Role of MicroShunts
Glaucoma is a leading cause of irreversible blindness, affecting over 79 million people globally .It’s characterized by progressive damage to the optic nerve, often caused by increased pressure inside the eye (intraocular pressure or IOP). While medications can definitely help manage IOP,some patients require surgical intervention.
The PRESERFLO MicroShunt is a miniature glaucoma drainage device implanted in the eye to reduce IOP. It works by creating a new pathway for fluid to drain from the eye, relieving pressure on the optic nerve. Approved for use in over 60 countries, it represents a significant advancement in glaucoma treatment. Though, as with any implant, ensuring it’s long-term functionality is paramount.
The Unexpected Culprit: Petrolatum-Based Eye ointments
For decades, petrolatum-based eye ointments have been a standard advice for managing dry eye and protecting the cornea, especially after eye surgery. They provide a protective barrier and lubrication.Though, the new research from Nagoya university demonstrates that the very properties that make these ointments effective – their occlusive nature and chemical composition – can be detrimental to the MicroShunt.
How Ointments Compromise the Implant
The study found that components within petrolatum-based ointments can cause a reaction with the MicroShunt’s material, leading to swelling of the shunt’s membrane. This swelling can obstruct the shunt’s drainage pathway,increasing IOP and potentially causing the implant to rupture. Researchers observed this effect both in laboratory experiments and in clinical cases of patients who experienced MicroShunt failure after using these ointments.
“We were surprised to find such a clear correlation,” explains Dr. Hiroki Mori, led author of the study. “These ointments are so commonly used, and patients frequently enough apply them liberally. Our research highlights the need for a reevaluation of post-operative care protocols for glaucoma patients with MicroShunts.”
What Does This Mean for Glaucoma Patients?
If you have a PRESERFLO MicroShunt implant, it’s crucial to discuss your eye care routine with your ophthalmologist. Here’s what you need to know:
- Avoid Petrolatum-based Ointments: The primary recommendation is to discontinue the use of any eye ointment containing petrolatum, mineral oil, or similar petroleum-derived ingredients.
- explore alternatives: Your doctor can recommend alternative lubricating eye drops or ointments that are compatible with the MicroShunt. These may include those based on hyaluronic acid,carboxymethylcellulose,or other non-petrolatum ingredients.
- Report Any Symptoms: If you experiance any sudden increase in eye pressure, pain, blurred vision, or other concerning symptoms after using an eye ointment, contact your ophthalmologist promptly.
- Review Post-Operative Instructions: Ensure your post-operative instructions are up-to-date and reflect this new understanding of potential ointment-related complications.
Identifying Petrolatum in Eye Ointments
Reading the ingredient list is key. look for these ingredients, which indicate a petrolatum base:
- Petrolatum
- Mineral Oil
- Petroleum jelly
- Paraffin
Many popular over-the-counter eye ointments contain these ingredients. Don’t hesitate to ask your pharmacist for assistance in identifying suitable alternatives.
The Future of Glaucoma Implant Care
This research underscores the importance of ongoing vigilance and adaptation in medical practice. The findings from Nagoya University are prompting a reassessment of post-operative care guidelines for MicroShunt recipients. Further research is underway to investigate the long-term effects of petrolatum exposure on the implant and to develop more biocompatible materials for future generations of glaucoma drainage devices.
For patients and ophthalmologists alike, this finding serves as a critical reminder that even seemingly benign products can have unintended consequences. Open interaction between patients and their doctors, coupled with a commitment to evidence-based care, is essential for preserving vision and improving the quality of life for those living with glaucoma.
Frequently Asked questions (FAQ)
- Q: I have a MicroShunt implant. Should I panic?
A: No. This research doesn’t mean your implant will automatically fail. It highlights a potential risk, and taking proactive steps – like discussing your eye care routine with your doctor and avoiding petrolatum-based ointments – can significantly reduce that risk.
- Q: What are good alternatives to petrolatum-based eye ointments?
A: Your ophthalmologist can recommend alternatives based on your specific needs. Options include lubricating eye drops and ointments containing hyaluronic acid or carboxymethylcellulose.
- Q: How long after surgery can I safely use eye ointments?
A: The timing varies depending on individual healing and your surgeon’s instructions. This new research suggests avoiding petrolatum-based ointments altogether after MicroShunt implantation.
Key Takeaways:
- Petrolatum-based eye ointments can cause swelling and potential rupture of PRESERFLO MicroShunt glaucoma implants.
- Patients with microshunts should avoid these ointments and discuss alternatives with their ophthalmologist.
- This research highlights the importance of ongoing vigilance and adaptation in glaucoma care.
